GMED Insider Trading

Insider Ownership Percentage: 18.54%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $15,991,541.53

Globus Medical Insider Trading History Chart

This chart shows the insider buying and selling history at Globus Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$1.25MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$5M$0$5MTotal Insider BuyingTotal Insider Selling

Globus Medical Share Price & Price History

Current Price: $92.33
Price Change: Price Increase of +1.527 (1.68%)
As of 01/21/2025 04:59 PM ET

This chart shows the closing price history over time for GMED up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
FebMarAprMayJunJulAugSepOctNovDecJan$90.83Closing price on 01/20/25:

SEC Filings (Institutional Ownership Changes) for Globus Medical (NYSE:GMED)

95.16% of Globus Medical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GMED by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$40Mbought$8.46MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1B$0$1BTotal InflowsTotal Outflows
Globus Medical logo
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Read More on Globus Medical

Today's Range

Now: $92.33
Low: $91.46
High: $92.42

50 Day Range

MA: $84.25
Low: $81.10
High: $90.84

52 Week Range

Now: $92.33
Low: $49.33
High: $92.42

Volume

1,545,506 shs

Average Volume

1,439,245 shs

Market Capitalization

$12.57 billion

P/E Ratio

137.80

Dividend Yield

N/A

Beta

1.19

Who are the company insiders with the largest holdings of Globus Medical?

Globus Medical's top insider investors include:
  1. David D Davidar (Director)
  2. Ann D Rhoads (Director)
  3. Leslie V Norwalk (Director)
  4. Dan Lemaitre (Director)
  5. Daniel T Scavilla (CEO)
  6. Keith W Pfeil (CFO)
  7. Kelly Huller (SVP)
Learn More about top insider investors at Globus Medical.

Who are the major institutional investors of Globus Medical?

Globus Medical's top institutional investors include:
  1. Artemis Investment Management LLP — 0.38%
  2. Fort Washington Investment Advisors Inc. OH — 0.30%
  3. Kathmere Capital Management LLC — 0.21%
  4. Covea Finance — 0.18%
  5. Exchange Traded Concepts LLC — 0.12%
  6. Assenagon Asset Management S.A. — 0.07%
Learn More about top institutional investors of Globus Medical stock.

Which institutional investors are selling Globus Medical stock?

During the previous quarter, GMED stock was sold by these institutional investors:
  1. Covea Finance
  2. Exchange Traded Concepts LLC
  3. Diversified Trust Co
  4. Janney Montgomery Scott LLC
  5. Radnor Capital Management LLC
  6. Hennion & Walsh Asset Management Inc.
  7. Profit Investment Management LLC
Within the last year, company insiders that have sold Globus Medical company stock include:
  1. David D Davidar (Director)
  2. Ann D Rhoads (Director)
  3. Leslie V Norwalk (Director)
  4. Dan Lemaitre (Director)
  5. Daniel T Scavilla (CEO)
  6. Keith W Pfeil (CFO)
  7. Kelly Huller (SVP)
Learn More investors selling Globus Medical stock.

Which institutional investors are buying Globus Medical stock?

Within the previous quarter, GMED stock was bought by institutional investors including:
  1. Kathmere Capital Management LLC
  2. Artemis Investment Management LLP
  3. Assenagon Asset Management S.A.
  4. Encompass More Asset Management
  5. Oak Thistle LLC
  6. HB Wealth Management LLC
  7. Everence Capital Management Inc.
  8. Park Avenue Securities LLC